Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.

Lass-Flörl C, Mutschlechner W, Aigner M, Grif K, Marth C, Girschikofsky M, Grander W, Greil R, Russ G, Cerkl P, Eller M, Kropshofer G, Eschertzhuber S, Kathrein H, Schmid S, Beer R, Lorenz I, Theurl I, Nachbaur D. J Clin Microbiol. 2013 Mar,51(3):863-8. doi: 10.1128/JCM.02965-12. Epub 2012 Dec 26.

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.

Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M Ann Oncol. 2013 Mar,24(3):640-7. doi: 10.1093/annonc/mds334. Epub 2012 Oct 3.

A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.

Namberger K, Weiss L, Krause B, Melchardt T, Greil R. Eur J Haematol. 2013 Apr,90(4):349-50. doi: 10.1111/ejh.12065. Epub 2013 Feb 14.

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.

Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R. Br J Cancer. 2013 Aug 6,109(3):589-96. doi: 10.1038/bjc.2013.367. Epub 2013 Jul 18.

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma.

Stenner-Liewen F, GrГјnwald V, Greil R, Porta C. Expert Rev Anticancer Ther. 2013 Sep,13(9):1021-33. doi: 10.1586/14737140.2013.833684. Epub 2013 Sep 12.

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Troch M, Kiesewetter B, Willenbacher W, Willenbacher E, Zebisch A, Linkesch W, Fridrik M, MГјllauer L, Greil R, Raderer M. Haematologica. 2013 Feb,98(2):264-8. doi: 10.3324/haematol.2012.072587. Epub 2012 Sep 14.

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.

Goetz MP, Suman VJ, Hoskin TL, Gnant M, Filipits M, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ames MM, Ingle JN. Clin Cancer Res. 2013 Jan 15,19(2):500-7. doi: 10.1158/1078-0432.CCR-12-2153. Epub 2012 Dec 4.

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).

Gaidzik VI, Schlenk RF, Paschka P, Stölzle A, Späth D, Kuendgen A, von Lilienfeld-Toal M, Brugger W, Derigs HG, Kremers S, Greil R, Raghavachar A, Ringhoffer M, Salih HR, Wattad M, Kirchen HG, Runde V, Heil G, Petzer AL, Girschikofsky M, Heuser M, Kayser S, et al. Blood. 2013 Jun 6,121(23):4769-77. doi: 10.1182/blood-2012-10-461624. Epub 2013 Apr 30.

Circulating tumor DNA to monitor metastatic breast cancer.

Weiss L, Hufnagl C, Greil R. N Engl J Med. 2013 Jul 4,369(1):93. doi: 10.1056/NEJMc1306040#SA2.

AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.

Gianni L, Romieu GH, Lichinitser M, Serrano SV, Mansutti M, Pivot X, Mariani P, Andre F, Chan A, Lipatov O, Chan S, Wardley A, Greil R, Moore N, Prot S, Pallaud C, Semiglazov V. J Clin Oncol. 2013 May 10,31(14):1719-25. doi: 10.1200/JCO.2012.44.7912. Epub 2013 Apr 8.